Skip to main content
RDHL
NASDAQ Life Sciences

RedHill Biopharma Expands ATM Offering by $1.59M, Totaling $1.85M, Signaling Significant Dilution Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.01
Mkt Cap
$5.295M
52W Low
$0.71
52W High
$3.31
52W Position info
42% above low
Off High info
69% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

RDHL sits 42% above its 52-week low of $0.71 on elevated volume (1.8× avg).

Summary

RedHill Biopharma has increased its At-The-Market (ATM) offering capacity by an additional $1.59 million, bringing the total potential raise under the program to $1.85 million, a highly dilutive move for the micro-cap company.


Key Events · Financing and Capital Events · RDHL

  • Increased ATM Capacity

    RedHill Biopharma has increased its At-The-Market (ATM) offering capacity by an additional $1,587,708.

  • Total Potential Raise

    The total potential capital raise under the ATM program, including previously sold amounts, now stands at approximately $1,854,912.

  • Significant Dilution

    This expanded offering represents a substantial portion of the company's current market capitalization, indicating significant potential dilution for existing shareholders.

  • Existing Program Update

    This filing supplements an existing ATM offering agreement established on February 3, 2025, and follows previous prospectus supplements.


Analysis · RDHL · Life Sciences

This 424B5 filing significantly expands RedHill Biopharma's At-The-Market (ATM) offering program, authorizing the sale of an additional $1.59 million in ADSs. This brings the total potential capital raise under the existing ATM program to $1.85 million. While highly dilutive, this capital raise is critical for the company, especially in light of the "going concern" warning disclosed in its recent 20-F filing. The company has already sold $267,204 under this program. The continuous sale of shares through an ATM program creates an overhang on the stock price, but securing capital is essential for extending the company's operational runway. Investors should monitor the pace and pricing of these sales.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RDHL was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.71 to $3.31. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RDHL - Latest Insights

RDHL
Oct 07, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4981
Real-time Price: $0.4279 info
Change: -$0.0702 (-14%) info
Market Cap: $3.751M info
RDHL
Sep 30, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4797
Real-time Price: $0.4279 info
Change: -$0.0518 (-11%) info
Market Cap: $3.751M info
RDHL
Sep 01, 2026, 7:10 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.9195
Real-time Price: $0.4279 info
Change: -$0.4916 (-53%) info
Market Cap: $3.751M info
RDHL
Sep 01, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.9016
Real-time Price: $0.4279 info
Change: -$0.4737 (-53%) info
Market Cap: $3.751M info
RDHL
Aug 31, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.6303
Real-time Price: $0.4279 info
Change: -$0.2024 (-32%) info
Market Cap: $3.751M info